Medpace Enterprise Value vs Interest Expense Analysis
MEDP Stock | USD 374.32 8.12 2.12% |
Medpace Holdings financial indicator trend analysis is infinitely more than just investigating Medpace Holdings recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medpace Holdings is a good investment. Please check the relationship between Medpace Holdings Enterprise Value and its Interest Expense accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.
Enterprise Value vs Interest Expense
Enterprise Value vs Interest Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medpace Holdings Enterprise Value account and Interest Expense. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Medpace Holdings' Enterprise Value and Interest Expense is -0.26. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Interest Expense in the same time period over historical financial statements of Medpace Holdings, assuming nothing else is changed. The correlation between historical values of Medpace Holdings' Enterprise Value and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of Medpace Holdings are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Enterprise Value i.e., Medpace Holdings' Enterprise Value and Interest Expense go up and down completely randomly.
Correlation Coefficient | -0.26 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Enterprise Value
Enterprise Value (or EV) is usually referred to as Medpace Holdings theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Medpace Holdings debt, but would also pocket its cash. Enterprise Value is more accurate representation of Medpace Holdings value than its market capitalization because it takes into account all of Medpace Holdings existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Most indicators from Medpace Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medpace Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.As of 04/19/2024, Sales General And Administrative To Revenue is likely to grow to 0.12, while Selling General Administrative is likely to drop slightly above 95.9 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 328.2M | 432.4M | 524.5M | 278.6M | Total Revenue | 1.1B | 1.5B | 1.9B | 2.0B |
Medpace Holdings fundamental ratios Correlations
Click cells to compare fundamentals
Medpace Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medpace Holdings fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 37.6M | 37.7M | 37.7M | 33.7M | 31.8M | 29.1M | |
Total Assets | 1.1B | 1.4B | 1.7B | 1.4B | 1.7B | 1.3B | |
Short Long Term Debt Total | 45.2M | 115.1M | 131.0M | 188.9M | 142.1M | 156.5M | |
Other Current Liab | 19.0M | 23.5M | 27.6M | 257.7M | 40.4M | 70.6M | |
Total Current Liabilities | 343.0M | 440.1M | 557.2M | 803.5M | 925.1M | 971.4M | |
Total Stockholder Equity | 726.3M | 805.8M | 952.9M | 386.4M | 559.0M | 654.5M | |
Other Liab | 28.6M | 29.6M | 18.8M | 23.8M | 21.4M | 20.0M | |
Net Tangible Assets | 9.5M | 96.9M | 249.2M | (314.0M) | (361.1M) | (379.2M) | |
Property Plant And Equipment Net | 99.4M | 198.8M | 222.7M | 248.9M | 265.4M | 138.1M | |
Current Deferred Revenue | 192.4M | 255.7M | 344.6M | 462.7M | 559.9M | 587.9M | |
Net Debt | (86.7M) | (162.6M) | (330.3M) | 160.6M | (103.3M) | (98.2M) | |
Retained Earnings | 68.1M | 115.2M | 235.0M | (359.8M) | (221.6M) | (210.6M) | |
Accounts Payable | 22.4M | 26.6M | 25.7M | 33.1M | 31.9M | 21.9M | |
Cash | 131.9M | 277.8M | 461.3M | 28.3M | 245.4M | 143.1M | |
Non Current Assets Total | 826.0M | 917.0M | 969.0M | 1.0B | 1.1B | 1.0B | |
Non Currrent Assets Other | 9.5M | 8.8M | 17.4M | 21.1M | 25.0M | 26.2M | |
Other Assets | 9.9M | 123.1M | 42.6M | 69.2M | 79.6M | 83.6M | |
Cash And Short Term Investments | 131.9M | 277.8M | 461.3M | 28.3M | 245.4M | 143.1M | |
Net Receivables | 155.7M | 161.0M | 186.4M | 253.4M | 298.4M | 163.0M | |
Common Stock Total Equity | 355K | 356K | 360K | 309K | 278.1K | 279.2K | |
Liabilities And Stockholders Equity | 1.1B | 1.4B | 1.7B | 1.4B | 1.7B | 1.3B | |
Non Current Liabilities Total | 73.8M | 144.8M | 149.8M | 162.6M | 172.7M | 182.2M | |
Other Current Assets | 29.4M | 34.9M | 43.2M | 52.3M | 50.0M | 32.1M | |
Other Stockholder Equity | 660.6M | 690.3M | 722.4M | 758.3M | 790.4M | 699.5M | |
Total Liab | 416.8M | 584.9M | 707.0M | 966.1M | 1.1B | 685.5M | |
Deferred Long Term Liab | 12.8M | 13.6M | 1.1M | 1.1M | 1.2M | 1.2M | |
Property Plant And Equipment Gross | 99.4M | 198.8M | 222.7M | 248.9M | 344.8M | 362.0M | |
Total Current Assets | 317.0M | 473.7M | 690.9M | 334.0M | 593.8M | 338.7M | |
Accumulated Other Comprehensive Income | (2.7M) | (131K) | (4.8M) | (12.4M) | (10.1M) | (9.6M) | |
Short Term Debt | 109.3M | 134.4M | 159.3M | 50M | 293.0M | 307.6M | |
Intangible Assets | 54.4M | 46.5M | 41.4M | 38.0M | 35.8M | 34.0M | |
Common Stock | 355K | 356K | 360K | 309K | 308K | 275.9K | |
Property Plant Equipment | 99.4M | 85.0M | 93.2M | 109.8M | 126.3M | 74.3M | |
Capital Surpluse | 666.6M | 695.9M | 727.9M | 770.8M | 886.4M | 714.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Medpace Stock analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.165 | Earnings Share 8.87 | Revenue Per Share 61.384 | Quarterly Revenue Growth 0.265 | Return On Assets 0.1399 |
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.